Task: Answer the multiple-choice question.
Question: Which drug exhibits a 45.933% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. Cc1ccc(NC(=O)C2CCCN2C(=O)Oc2ccccc2)cc1C
b. Nc1ccccc1/C=N\N=C/c1ccccc1N
c. CCOCc1nnc(NC(=O)c2ccc(NC(C)=O)cc2)s1
Answer: c. CCOCc1nnc(NC(=O)c2ccc(NC(C)=O)cc2)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOCc1nnc(NC(=O)c2ccc(NC(C)=O)cc2)s1
CCOCc1nnc(NC(=O)c2ccc(NC(C)=O)cc2)s1
4-acetamido-N-[5-(ethoxymethyl)-1,3,4-thiadiazol-2-yl]benzamide